Skin disease caused by bacterial infection
MONDO:0024295Skin diseases caused by bacteria.
Also known as: Bacteria caused skin disease caused by infection, Bacteria skin disease caused by infection, bacterial skin disease, bacterial skin diseases, disease, bacterial skin, diseases, bacterial skin, skin disease, bacterial
57 clinical trials for this condition and its sub-types, 13 tagged with Skin disease caused by bacterial infection itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Skin disease caused by bacterial infection
-
Cellulitis 29 trials · 31 incl. sub-types
3 sub-types
- Orbital cellulitis 3 trials
- Ludwig's angina 0 trials
- Anaerobic cellulitis 0 trials
-
Hordeolum 1 trial · 7 incl. sub-types
2 sub-types
- Internal hordeolum 1 trial · 6 incl. sub-types Sub-types →
- Hordeolum externum 0 trials
-
Impetigo 5 trials
2 sub-types
- Ecthyma 0 trials
- Impetigo herpetiformis 0 trials
-
Cutaneous anthrax 2 trials
-
Erysipelas 1 trial
-
Pinta disease 1 trial
-
Aquarium granuloma 0 trials
-
Bacillary angiomatosis 0 trials
-
Bacterial exanthem 0 trials
-
Bullous impetigo 0 trials
-
Cutaneous diphtheria 0 trials
-
Cutaneous syphilis 0 trials
1 sub-type
- Late yaws 0 trials
-
Cutaneous tuberculosis 0 trials
2 sub-types
- Lupus vulgaris 0 trials
- Primary cutaneous tuberculosis 0 trials
-
Gas gangrene 0 trials
-
Gonococcal keratitis 0 trials
-
Staphylococcal scalded skin syndrome 0 trials
-
Sycosis barbae 0 trials
Most studied deeper sub-types
-
New antibody drug aims to calm painful skin condition
Disease control OngoingThis Phase 2 trial tests tibulizumab, a dual-action antibody, in 225 adults with hidradenitis suppurativa (HS), a chronic skin condition causing painful abscesses. Participants first receive either the drug or a placebo for 16 weeks, then everyone gets the drug for another 16 wee…
Phase 2 • Sponsor: Zura Bio Inc • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for HS sufferers: Long-Term drug trial expands
Disease control By invitation onlyThis study looks at the long-term safety and effectiveness of a drug called sonelokimab for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. About 835 adults and teens who completed an earlier sonelokimab study will receive the drug for an e…
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug trial aims to help teens with painful skin condition
Disease control OngoingThis study tests a drug called sonelokimab in 35 teenagers aged 12 to 17 with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition that causes painful lumps. The main goals are to see how the drug moves through the body and whether it is safe. Researchers wi…
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC